Literature DB >> 8685663

Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology.

S E Arnold1, J Q Trojanowski.   

Abstract

Recent clinical and neuropsychological studies have shown that severe deterioration in cognitive and functional capacities is prevalent in elderly, chronically hospitalized patients with schizophrenia. Postmortem studies of tissue from patients who were clinically well characterized have found notably little neurodegenerative or other pathology to explain the dementia. In contrast, several large studies using archival material have reported an unexpectedly high occurrence of Alzheimer's disease pathology in patients with schizophrenia irrespective of clinical status. Reasons for conflicting results likely include inaccuracies in psychiatric diagnoses but also could be due to differences in sample selection, treatment histories, and environmental influences. Thus, the neurobiological substrates for dementia in late-life schizophrenia remain uncertain. Further studies should incorporate standard diagnostic procedures with community-based and institutionalized schizophrenia patients as well as psychiatric control patients with similar treatment histories. These should apply sensitive neuropathological methods to assess disease-specific and nonspecific markers of neurodegeneration and dementia.

Entities:  

Mesh:

Year:  1996        PMID: 8685663     DOI: 10.1093/schbul/22.1.5

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  10 in total

Review 1.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

Review 2.  Very poor outcome schizophrenia: clinical and neuroimaging aspects.

Authors:  Serge A Mitelman; Monte S Buchsbaum
Journal:  Int Rev Psychiatry       Date:  2007-08

3.  Temporal lobe morphology in normal aging and traumatic brain injury.

Authors:  Erin D Bigler; Carol V Anderson; Duane D Blatter; Carol V Andersob
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

4.  Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness.

Authors:  Felix Geser; John L Robinson; Joseph A Malunda; Sharon X Xie; Chris M Clark; Linda K Kwong; Paul J Moberg; Erika M Moore; Vivianna M Van Deerlin; Virginia M-Y Lee; Steven E Arnold; John Q Trojanowski
Journal:  Arch Neurol       Date:  2010-10

5.  Age-related deficits in fronto-temporal connections in schizophrenia: a diffusion tensor imaging study.

Authors:  Gudrun Rosenberger; Marek Kubicki; Paul G Nestor; Erin Connor; Georgia B Bushell; Douglas Markant; Margaret Niznikiewicz; Carl-Fredrik Westin; Ron Kikinis; Andrew J Saykin; Robert W McCarley; Martha E Shenton
Journal:  Schizophr Res       Date:  2008-05-27       Impact factor: 4.939

6.  Health outcomes and cost of care among older adults with schizophrenia: a 10-year study using medical records across the continuum of care.

Authors:  Hugh C Hendrie; Wanzhu Tu; Rebeka Tabbey; Christianna E Purnell; Roberta J Ambuehl; Christopher M Callahan
Journal:  Am J Geriatr Psychiatry       Date:  2013-04-06       Impact factor: 4.105

Review 7.  The dementias of schizophrenia.

Authors:  Ricardo de Oliveira-Souza; Rogério Paysano Marrocos; Jorge Moll
Journal:  Dement Neuropsychol       Date:  2007 Apr-Jun

8.  Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease.

Authors:  Jeremy Koppel; Heidy Jimenez; Leslie Adrien; Blaine S Greenwald; Philippe Marambaud; Ezra Cinamon; Peter Davies
Journal:  Alzheimers Dement (N Y)       Date:  2016-06-21

Review 9.  Transgenerational Interaction of Alzheimer's Disease with Schizophrenia through Amyloid Evolvability.

Authors:  Yoshiki Takamatsu; Gilbert Ho; Masaaki Waragai; Ryoko Wada; Shuei Sugama; Takato Takenouchi; Eliezer Masliah; Makoto Hashimoto
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

10.  Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis.

Authors:  Taro Kishi; Toshikazu Ikuta; Kazuto Oya; Shinji Matsunaga; Yuki Matsuda; Nakao Iwata
Journal:  Int J Neuropsychopharmacol       Date:  2018-08-01       Impact factor: 5.176

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.